These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27942444)

  • 1. Practical, ethical and regulatory considerations for the evolving medical and research genomics landscape.
    Lyon GJ; Segal JP
    Appl Transl Genom; 2013 Dec; 2():34-40. PubMed ID: 27942444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controversy and debate on clinical genomics sequencing-paper 1: genomics is not exceptional: rigorous evaluations are necessary for clinical applications of genomic sequencing.
    Wilson BJ; Miller FA; Rousseau F
    J Clin Epidemiol; 2017 Dec; 92():4-6. PubMed ID: 28870871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethical issues raised by whole genome sequencing.
    Pinxten W; Howard HC
    Best Pract Res Clin Gastroenterol; 2014 Apr; 28(2):269-79. PubMed ID: 24810188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
    Beigh MM
    Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical issues in implementing whole-genome-sequencing in routine diagnostic microbiology.
    Rossen JWA; Friedrich AW; Moran-Gilad J;
    Clin Microbiol Infect; 2018 Apr; 24(4):355-360. PubMed ID: 29117578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical considerations surrounding germline next-generation sequencing of children with cancer.
    Johnson LM; Hamilton KV; Valdez JM; Knapp E; Baker JN; Nichols KE
    Expert Rev Mol Diagn; 2017 May; 17(5):523-534. PubMed ID: 28399664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing.
    Park ST; Kim J
    Int Neurourol J; 2016 Nov; 20(Suppl 2):S76-83. PubMed ID: 27915479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing genomic medicine in pathology.
    Williams ES; Hegde M
    Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethics and equity in rare disease research and healthcare.
    Koromina M; Fanaras V; Baynam G; Mitropoulou C; Patrinos GP
    Per Med; 2021 Jul; 18(4):407-416. PubMed ID: 34085867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
    Kamps R; Brandão RD; Bosch BJ; Paulussen AD; Xanthoulea S; Blok MJ; Romano A
    Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28146134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exome sequencing explained: a practical guide to its clinical application.
    Seaby EG; Pengelly RJ; Ennis S
    Brief Funct Genomics; 2016 Sep; 15(5):374-84. PubMed ID: 26654982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer Care.
    Surrey LF; Luo M; Chang F; Li MM
    Cytogenet Genome Res; 2016; 150(3-4):162-175. PubMed ID: 28002823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-exome/genome sequencing and genomics.
    Grody WW; Thompson BH; Hudgins L
    Pediatrics; 2013 Dec; 132(Suppl 3):S211-5. PubMed ID: 24298129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurology Individualized Medicine: When to Use Next-Generation Sequencing Panels.
    Klein CJ; Foroud TM
    Mayo Clin Proc; 2017 Feb; 92(2):292-305. PubMed ID: 28160876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Best approaches to drug-resistance surveillance at the country level.
    Cabibbe AM; Cirillo DM
    Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S40-S41. PubMed ID: 28043601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethical conundrums in pediatric genomics.
    Rotz SJ; Kodish E
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):301-306. PubMed ID: 30504324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lake Louise mutation detection meeting 2013: clinical translation of next-generation sequencing requires optimization of workflows and interpretation of variants.
    Smith A; Boycott KM; Jarinova O
    Hum Mutat; 2014 Feb; 35(2):265-9. PubMed ID: 24282140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.